Elosulfase alfa decreases glycosaminoglycan storage in white blood cells from Morquio syndrome type A patients undergoing enzyme replacement

2015 ◽  
Vol 114 (2) ◽  
pp. S17-S18
Author(s):  
Guilherme Baldo ◽  
Fabiano Poswar ◽  
Andressa Federhen ◽  
Rejane Gus ◽  
Fernanda Bender ◽  
...  
Keyword(s):  
Blood Cells ◽  
White Blood Cells ◽  
Type A ◽  
Syndrome Type ◽  
Enzyme Replacement ◽  
Morquio Syndrome ◽  
Elosulfase Alfa

The patient experience of elosulfase alfa treatment for MPS IVA (Morquio syndrome type A): beyond traditional measures

2017 ◽  
Vol 120 (1-2) ◽  
pp. S70-S71
Author(s):  
James Jarrett ◽  
Mohit Jain ◽  
Charlotte Roberts ◽  
Alexandra Morrison
Keyword(s):  
Patient Experience ◽  
Type A ◽  
Syndrome Type ◽  
Mps Iva ◽  
Morquio Syndrome ◽  
Elosulfase Alfa

Impact of two-year elosulfase alfa treatment on patient-reported outcomes in patients with Morquio syndrome type A: Results from an English managed access agreement

2019 ◽  
Vol 126 (2) ◽  
pp. S19
Author(s):  
Jacqueline Adam ◽  
Maureen Cleary ◽  
Christian Hendriksz ◽  
Tarekegn Geberhiwot ◽  
Derralynn Hughes ◽  
...  
Keyword(s):  
Patient Reported Outcomes ◽  
Type A ◽  
Syndrome Type ◽  
Patient Reported ◽  
Morquio Syndrome ◽  
Elosulfase Alfa

Elosulfase alfa treatment and changes in physical functioning and disability in Morquio syndrome type A

2017 ◽  
Vol 120 (1-2) ◽  
pp. S65 ◽  
Author(s):  
Christian J. Hendriksz ◽  
Rossella Parini ◽  
Moeenaldeen D. AlSayed ◽  
Julian Raiman ◽  
Roberto Giugliani ◽  
...  
Keyword(s):  
Physical Functioning ◽  
Type A ◽  
Syndrome Type ◽  
Morquio Syndrome ◽  
Elosulfase Alfa

Against all odds: enzyme replacement therapy in non-ambulatory and ambulatory Morquio syndrome type A patients

2019 ◽  
Vol 126 (2) ◽  
pp. S32
Author(s):  
Pedro Paulo F. Bozzo ◽  
Amanda C. Monteiro ◽  
Daniely P. Camara ◽  
Larissa F. Bissoli ◽  
Charles M. Lourenco
Keyword(s):  
Enzyme Replacement Therapy ◽  
Replacement Therapy ◽  
Type A ◽  
Syndrome Type ◽  
Enzyme Replacement ◽  
Morquio Syndrome

Impact of elosulfase alfa in patients with Morquio syndrome type A who have limited ambulation: An open-label, phase 2 study

2016 ◽  
Vol 117 (2) ◽  
pp. S55
Author(s):  
Paul R. Harmatz ◽  
Andrea Jester ◽  
Eugen Mengel ◽  
Marsha Treadwell ◽  
Barbara K. Burton ◽  
...  
Keyword(s):  
Type A ◽  
Syndrome Type ◽  
Phase 2 ◽  
Open Label ◽  
Phase 2 Study ◽  
Open Label Phase ◽  
Morquio Syndrome ◽  
Elosulfase Alfa

Impact of long-term elosulfase alfa treatment on pulmonary function in patients with Morquio syndrome type A

2016 ◽  
Vol 117 (2) ◽  
pp. S56 ◽  
Author(s):  
Christian J. Hendriksz ◽  
Barbara K. Burton ◽  
Moeen D. AlSayed ◽  
Roberto Giugliani ◽  
Norberto Guelbert ◽  
...  
Keyword(s):  
Pulmonary Function ◽  
Type A ◽  
Syndrome Type ◽  
Morquio Syndrome ◽  
Elosulfase Alfa

Clinical outcomes in Morquio syndrome type A treated with elosulfase alfa: results from the managed access agreement in England

2018 ◽  
Vol 123 (2) ◽  
pp. S67
Author(s):  
Derralynn Hughes ◽  
Maureen Cleary ◽  
Tarekegn Geberhiwot ◽  
Christian J. Hendriksz ◽  
Simon A. Jones ◽  
...  
Keyword(s):  
Clinical Outcomes ◽  
Type A ◽  
Syndrome Type ◽  
Morquio Syndrome ◽  
Elosulfase Alfa

Immunomodulation in a patient with Morquio syndrome type A treated with enzyme replacement therapy

2016 ◽  
Vol 117 (2) ◽  
pp. S18 ◽  
Author(s):  
Walaa Alshuaibi ◽  
Susan Hale ◽  
Daniel Petroni ◽  
Suzanne Skoda-Smith ◽  
Michael J. Goldberg ◽  
...  
Keyword(s):  
Enzyme Replacement Therapy ◽  
Replacement Therapy ◽  
Type A ◽  
Syndrome Type ◽  
Enzyme Replacement ◽  
Morquio Syndrome
Sign in / Sign up

Export Citation Format

Share Document